Adaptimmune Therapeutics PLC Quarterly Common Stock, Shares, Outstanding from Q2 2014 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Adaptimmune Therapeutics PLC quarterly Common Stock, Shares, Outstanding history and growth rate from Q2 2014 to Q3 2024.
  • Adaptimmune Therapeutics PLC Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 1.53B shares, a 12.7% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.53B +173M +12.7% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 1.53B +182M +13.5% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 1.53B +539M +54.3% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 1.36B +376M +38.1% Dec 31, 2023 10-Q 2024-11-13
Q3 2023 1.36B +379M +38.6% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 1.35B +375M +38.4% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 994M +52.8M +5.62% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 987M +58.6M +6.31% Dec 31, 2022 10-K 2024-03-06
Q3 2022 983M +45.7M +4.87% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 977M +40.5M +4.33% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 941M +8.05M +0.86% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 929M -207K -0.02% Dec 31, 2021 10-K 2023-03-06
Q3 2021 937M +8.52M +0.92% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 936M +8.57M +0.92% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 933M +152M +19.5% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 929M +298M +47.2% Dec 31, 2020 10-K 2022-03-14
Q3 2020 929M +298M +47.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 928M +297M +47.1% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 781M +152M +24.2% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 631M +3.55M +0.57% Dec 31, 2019 10-K 2021-02-25
Q3 2019 631M +3.73M +0.6% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 631M +64.2M +11.3% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 628M +63.4M +11.2% Mar 31, 2019 10-Q 2019-05-06
Q4 2018 627M +65.3M +11.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 627M +65.1M +11.6% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 566M +5.39M +0.96% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 565M +45.9M +8.84% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 562M +137M +32.3% Dec 31, 2017 10-K 2019-02-27
Q3 2017 562M +137M +32.4% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 561M +136M +32.1% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 519M +94.3M +22.2% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 425M +63.2K +0.02% Dec 31, 2016 10-K 2018-03-15
Q3 2016 425M Sep 30, 2016 10-Q 2016-11-10
Q2 2016 425M 0 0% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 425M Mar 31, 2016 10-Q 2016-05-12
Q4 2015 425M Dec 31, 2015 10-K 2017-03-13
Q2 2015 425M +243M +134% Jun 30, 2015 10-K 2017-03-13
Q2 2014 181M Jun 30, 2014 8-K 2016-07-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.